🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are excited to announce that we have raised $150 million in Series B financing to advance AI-driven precision medicine for gastroenterology. This round was co-led by Insight Partners & ClearlakeCap, and marks a total $182 million raised in 2021. businesswire.com/news/home/2022…

Iterative Scopes has entered a collaboration with Janssen Research & Development, LLC (JNJInnovative Medicine) to augment Janssen’s clinical trials for IBD with the deployment of cutting-edge artificial intelligence (AI) and computer vision tools. businesswire.com/news/home/2022…

Thank you Nasdaq for highlighting Iterative Scopes and our recent fundraise in Times Square!

Iterative Scopes is excited to announce that it has entered an AI-driven data sharing agreement with Pfizer to advance IBD clinical trials. businesswire.com/news/home/2022…

With the addition of CRSG and Precision, Iterative Scopes has the opportunity to work more closely with different types of clinical trial sites and providers and to gain sophisticated insights about their needs and pain points. businesswire.com/news/home/2022…

At Digestive Disease Week 2022, Iterative Scopes presented data created in collaboration with Former Account of Eli Lilly and Company demonstrating how AI can improve endoscopic-disease severity scoring in ulcerative colitis. #DDW2022 businesswire.com/news/home/2022…

Iterative Scopes announced at #DDW2022 that its computer-aided device, SKOUT(™), demonstrates statistical superiority at overall adenoma detection compared to routine colonoscopy.  Aasma Shaukat MD MPH businesswire.com/news/home/2022…

This morning, Clinical Research News published an article written by Iterative Scopes SVP of Clinical Strategy, Chris Fourment, MD (Chris Fourment, MD) on the topic, “How AI and Computer Vision Can Solve Challenges in IBD Drug Development” clinicalresearchnewsonline.com/news/2022/06/2… #gastroenterology

Laura Mantell (Laura Mantell) joins Iterative Scopes as VP of Life Sciences. In support of the company’s goal to help optimize IBD clinical trials, she will steer all life sciences, biopharma, and biotech partnerships. #artificialintelligence businesswire.com/news/home/2022…

In a video with Marouane Derfoufi Magazine, Aasma Shaukat MD MPH discusses data from our DDW 2022 late-breaking abstract showing that SKOUT™ demonstrated statistical superiority at overall adenoma detection compared to routine colonoscopy. Not currently for sale in the US. bit.ly/3vk1mei

Check out our new video to learn how Iterative Scopes aims to revolutionize gastroenterology by delivering precision medicine and quality care to IBD patients. #ibd

Built In San Francisco recently interviewed our Chief Product Officer Brice Wu to learn what a culture of ownership means for his team. bit.ly/3djHySm

The registration study for our real-time computer-aided polyp detection device SKOUT™ is featured on the cover of Gastroenterology! Check out the September issue to read our registration study results. SKOUT is not yet for sale in the US. Provation gastrojournal.org/article/S0016-…

We’re thrilled to announce that our real-time, computer-aided, polyp detection device SKOUT™ has received 510(k) clearance from the FDA. Read our new release to learn more about our registration study. SKOUT is not yet for sale in the US. Provation businesswire.com/news/home/2022…

Iterative Scopes announces a new partnership with One GI® to bring AI-Recruitment to their clinical research, starting at Gastro One. Through this collaboration, both organizations hope to better democratize access to novel IBD therapeutics. Robbie Allen bwnews.pr/3S0bf9w

Iterative Scopes is now Iterative Health! With this re-branding, we reinforce our commitment to advancing precision medicine and continuing to raise the bar for both accuracy and consistency in physician decision-making. Visit our new website: iterative.health

We’re on the list! Excited to share that Iterative Health has been included in Built In's Best Midsize Places to Work List in Boston! #2023BuiltInBest businesswire.com/news/home/2023…

Iterative Health is excited to announce a partnership with Florida Research Institute to bring AI Recruitment (AIR) technology to Florida, to help democratize access to novel IBD therapeutics for all patients, regardless of where they receive care. Florida Digestive Health Specialists businesswire.com/news/home/2023…

Join us live on YouTube tomorrow at 10:30 a.m. ET for a discussion about Observing Ramadan With IBD in partnership with @southasianIBD and ImproveCareNow™. Watch live: bit.ly/3Ftujtk

We're thrilled to announce that SKOUT®: real-time AI for polyp detection, will soon be available to gastroenterologists throughout the United States. Learn more about the latest technology for enhanced adenoma detection here: businesswire.com/news/home/2023… Provation